Islamic marketing

Celularity Announces $45 Million Purchase Order, First Middle East Private Label Agreement For Celularity’s Halal-Certified Biomaterial Products

Retrieved on: 
Tuesday, May 23, 2023
CELU, Instituto de Biologia Molecular e Celular, Islamic marketing, Regenerative medicine, CH, Patient, Halal, Physician, Certification, Kingdom, Medical device, Cryptocurrency

Celularity biomaterial products are manufactured in its state-of-the-art cGMP/cGTP compliant facility located in Florham Park, New Jersey

Key Points: 
  • Celularity biomaterial products are manufactured in its state-of-the-art cGMP/cGTP compliant facility located in Florham Park, New Jersey
    FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, today announced that it has received a $45 million purchase order for Celularity private label Halal-Certified biomaterial products from Jamjoom Medical Store (Jamjoom).
  • This marks the first purchase order received by Celularity under its recently announced expansion into the Middle East market, as part of Celularity’s global market strategy.
  • “We are delighted today to announce receipt of a $45 million purchase order for private label Celularity Halal-Certified biomaterial products from Jamjoom.
  • “We are excited to partner with Jamjoom as the first private label distributor of these products in the Kingdom.”

CELULARITY ANNOUNCES $45 MILLION PURCHASE ORDER, FIRST MIDDLE EAST PRIVATE LABEL AGREEMENT FOR CELULARITY'S HALAL-CERTIFIED BIOMATERIAL PRODUCTS

Retrieved on: 
Tuesday, May 23, 2023
CELU, Instituto de Biologia Molecular e Celular, Islamic marketing, Regenerative medicine, CH, Patient, Physician, Halal, Certification, Halal certification in Australia, Medical device, Kingdom

Robert J. Hariri, M.D., Ph.D., Celularity's CEO, Chairman and Founder, said: "We are delighted to announce the receipt of a $45 million purchase order for Celularity Halal-Certified biomaterial products from Jamjoom, marking an important step in our expansion into the Middle East.

Key Points: 
  • Robert J. Hariri, M.D., Ph.D., Celularity's CEO, Chairman and Founder, said: "We are delighted to announce the receipt of a $45 million purchase order for Celularity Halal-Certified biomaterial products from Jamjoom, marking an important step in our expansion into the Middle East.
  • Celularity's investment in platform technologies and infrastructure, including our world class cGMP/cGTP-compliant manufacturing facility allows us to rapidly scale and efficiently manufacture our Halal-certified biomaterial products.
  • Dr. Khalid Ali, Jamjoom CEO, said: "As the first private label distributor of Celularity Halal-Certified biomaterial products in the Kingdom of Saudi Arabia, this purchase order marks our commitment to bringing innovative regenerative medicine products to physicians and patients alike.
  • "We are excited to partner with Jamjoom as the first private label distributor of these products in the Kingdom."

CELULARITY ANNOUNCES $45 MILLION PURCHASE ORDER, FIRST MIDDLE EAST PRIVATE LABEL AGREEMENT FOR CELULARITY'S HALAL-CERTIFIED BIOMATERIAL PRODUCTS

Retrieved on: 
Tuesday, May 23, 2023
CELU, Instituto de Biologia Molecular e Celular, Islamic marketing, Regenerative medicine, CH, Patient, Physician, Halal, Certification, Halal certification in Australia, Medical device, Kingdom

Robert J. Hariri, M.D., Ph.D., Celularity's CEO, Chairman and Founder, said: "We are delighted to announce the receipt of a $45 million purchase order for Celularity Halal-Certified biomaterial products from Jamjoom, marking an important step in our expansion into the Middle East.

Key Points: 
  • Robert J. Hariri, M.D., Ph.D., Celularity's CEO, Chairman and Founder, said: "We are delighted to announce the receipt of a $45 million purchase order for Celularity Halal-Certified biomaterial products from Jamjoom, marking an important step in our expansion into the Middle East.
  • Celularity's investment in platform technologies and infrastructure, including our world class cGMP/cGTP-compliant manufacturing facility allows us to rapidly scale and efficiently manufacture our Halal-certified biomaterial products.
  • Dr. Khalid Ali, Jamjoom CEO, said: "As the first private label distributor of Celularity Halal-Certified biomaterial products in the Kingdom of Saudi Arabia, this purchase order marks our commitment to bringing innovative regenerative medicine products to physicians and patients alike.
  • "We are excited to partner with Jamjoom as the first private label distributor of these products in the Kingdom."

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023
Oncology, Health, Infectious Diseases, Logistics, Supply Chain Management, Transport, Pharmaceutical, Biotechnology, Gulf Cooperation Council, Degenerative disease, Umbilical cord, Organisation of Islamic Cooperation, Trauma, Product distribution, Partnership, CELU, CH, Placenta, Instituto de Biologia Molecular e Celular, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., Wound healing, Islamic marketing, African Union, Organization, United Arab Emirates, Regenerative medicine, Pharmaceutical industry, Silk

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.

Key Points: 
  • Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity’s previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity’s Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • “Based on market demand for Celularity’s commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets,” said Sayed Zayan, CEO of CH Trading Group.

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023
Gulf Cooperation Council, Degenerative disease, Umbilical cord, Organisation of Islamic Cooperation, Trauma, Health, Product distribution, Partnership, CELU, CH, Placenta, Instituto de Biologia Molecular e Celular, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., Wound healing, Islamic marketing, African Union, Organization, United Arab Emirates, Regenerative medicine, Islam, Silk, Pharmaceutical industry

FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement. CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries. The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.   

Key Points: 
  • Relationship opens access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products across the Middle East and the broader Islamic world
    FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • "Based on market demand for Celularity's commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets," said Sayed Zayan,  CEO of CH Trading Group.

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023
Gulf Cooperation Council, Degenerative disease, Umbilical cord, Organisation of Islamic Cooperation, Trauma, Health, Product distribution, Partnership, CELU, CH, Placenta, Instituto de Biologia Molecular e Celular, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., Wound healing, Islamic marketing, African Union, Organization, United Arab Emirates, Regenerative medicine, Islam, Silk, Pharmaceutical industry

FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement. CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries. The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.   

Key Points: 
  • Relationship opens access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products across the Middle East and the broader Islamic world
    FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • "Based on market demand for Celularity's commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets," said Sayed Zayan,  CEO of CH Trading Group.

Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, January 11, 2023
Gulf Cooperation Council, Degenerative disease, LifeBank, Umbilical cord, Vision 2030, Public health, Organisation of Islamic Cooperation, Trauma, Partner (business rank), Health, CELU, Therapy, CH, Placenta, Research, Wound healing, Islamic marketing, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., African Union, Pakistan and the Organisation of Islamic Cooperation, Organization, United Arab Emirates, Silk, Weapon, Medical device, Kingdom, Instituto de Biologia Molecular e Celular

FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer"). The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.

Key Points: 
  • Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products
    FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer").
  • The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.
  • "Saudi Arabia is a prime market for Celularity's commercial regenerative biomaterial products," said CEO of CH Trading Group, Sayed Zayan.
  • "We are excited to partner with Tamer Group and to be a part of fulfilling their commitment to the development of the Kingdom's healthcare sector."

Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, January 11, 2023
Gulf Cooperation Council, Degenerative disease, LifeBank, Umbilical cord, Vision 2030, Public health, Organisation of Islamic Cooperation, Trauma, Partner (business rank), Health, CELU, Therapy, CH, Placenta, Research, Wound healing, Islamic marketing, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., African Union, Pakistan and the Organisation of Islamic Cooperation, Organization, United Arab Emirates, Silk, Medical device, Kingdom, Instituto de Biologia Molecular e Celular

FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia , Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer"). The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.

Key Points: 
  • Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products
    FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia , Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer").
  • The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.
  • "Saudi Arabia is a prime market for Celularity's commercial regenerative biomaterial products," said CEO of CH Trading Group, Sayed Zayan.
  • "We are excited to partner with Tamer Group and to be a part of fulfilling their commitment to the development of the Kingdom's healthcare sector."

Fifteen WPP Leaders Recognised for Championing Inclusion and Diversity in the Workplace

Retrieved on: 
Thursday, May 19, 2022
Other Communications, Finance, Public Relations, Investor Relations, Marketing, Advertising, Banking, Communications, Professional Services, People, Digital, Executive, Equity, Corporate Affairs, Health, Goal, Islamic marketing, Founder CEO, BCW, Black, Involve, APAC, Culture, Ambition Institute, EMEA, Creativity, Partnership, DE, Update, Human, Commerce, Advocate, Yahoo! Finance, WPP, NYSE, CEO, VMLY&R, Advertising, Management, Ogilvy, GroupMe, Media, Kantar

Fifteen leaders from across WPP (NYSE: WPP) have been named in the global Empower Role Model Lists 2022 for breaking down barriers and driving inclusion for people of colour in business.

Key Points: 
  • Fifteen leaders from across WPP (NYSE: WPP) have been named in the global Empower Role Model Lists 2022 for breaking down barriers and driving inclusion for people of colour in business.
  • VMLY&Rs Group Director, Client Engagement Nikeisha Beckford and Senior Talent Development Manager Francis Carrero-Green both feature on the Future Leaders list.
  • Mark Read, CEO of WPP, said: For WPP, a diverse and inclusive culture is a business opportunity as well as an imperative.
  • All the individuals within these lists are championing inclusion and, most importantly, leveraging their expertise and knowledge to drive inclusion initiatives and strategic change within their organisations.

CH GROUP ANNOUNCES AMERICAN FOOTBALL AND SPORTS MEDICINE INITIATIVES IN CELEBRATION OF 91ST SAUDI NATIONAL DAY

Retrieved on: 
Thursday, October 7, 2021
GEA, Laurel, Private law, List of health departments and ministries, Lists of World Heritage Sites, Halal, NGO, Culture, Custodian of the Two Holy Mosques, GLOBE, CH, Tourism, Islam, PIF, Muslim world, VIP, Ministry of Sports of Saudi Arabia, General Entertainment, Certification, NFLA, American football, Ministry of Health (Saudi Arabia), Islamic marketing, NFL, Initiative, International development, Sports medicine, Leadership, Solution, Cosmetics, Government, Ministry, Royal, Technology, Athlete, National Football League Alumni, Interior design, Weapon, Medicine

Commenting on the Initiatives, CH Group Chairman/CEO Elsayed Zayan stated, Allow me first to share congratulations regarding celebration of the Kingdoms 91st anniversary from its founding.

Key Points: 
  • Commenting on the Initiatives, CH Group Chairman/CEO Elsayed Zayan stated, Allow me first to share congratulations regarding celebration of the Kingdoms 91st anniversary from its founding.
  • CH Group is proud to be a partner in Saudi Arabias social and economic growth as A Home for Us.
  • This announcement will be followed by a VIP Diplomatic Trip to Saudi Arabia by US participants in the Initiatives.
  • The CH family of companies and affiliates (CH Group) encompass a diversified conglomerate engaged in a variety of multi-national business products, services and solutions.